How many institutions held PASG - Passage BIO, Inc. - Common Stock, par value $0.0001 per share in Q1 2021?

88 institutional investors reported PASG - Passage BIO, Inc. - Common Stock, par value $0.0001 per share for Q1 2021. Use the holders table for investor-level position and value details.

Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG)

Q: What does CUSIP 702712100 represent in this 13F holders report?

CUSIP 702712100 is the security identifier for PASG - Passage BIO, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

CUSIP: 702712100

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 3,182,163
Total 13F shares: 44,993,194
Share change: +13,012,824
Total reported value: $786,465,406
Price per share: $17.48
Number of holders: 88
Value change: +$223,951,633
Number of buys: 61
Number of sells: 16

Quarterly Holders Quick Answers

What is CUSIP 702712100?
CUSIP 702712100 identifies PASG - Passage BIO, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 702712100:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of PASG - Passage BIO, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ORBIMED ADVISORS LLC	13F	Company	219%	6,962,899	$178,041,000	—	31 Dec 2020	13F
FMR LLC	13F	Company	166%	5,278,100	$134,961,000	—	31 Dec 2020	13F
FRAZIER MANAGEMENT LLC	13F	Company	157%	5,009,219	$128,086,000	—	31 Dec 2020	13F
New Leaf Venture Partners, L.L.C.	13F	Company	78%	2,497,922	$63,872,000	—	31 Dec 2020	13F
BlackRock Finance, Inc.	13F	Company	70%	2,213,700	$56,606,000	—	31 Dec 2020	13F
Boxer Capital, LLC	13F	Company	61%	1,928,315	$49,307,000	—	31 Dec 2020	13F
Vivo Capital, LLC	13F	Company	47%	1,487,038	$38,024,000	—	31 Dec 2020	13F
VANGUARD GROUP INC	13F	Company	31%	986,794	$25,233,000	—	31 Dec 2020	13F
HIGHLINE CAPITAL MANAGEMENT, L.P.	13F	Company	19%	602,248	$15,399,000	—	31 Dec 2020	13F
MORGAN STANLEY	13F	Company	13%	424,348	$10,851,000	—	31 Dec 2020	13F
STATE STREET CORP	13F	Company	12%	393,916	$10,072,000	—	31 Dec 2020	13F
Logos Global Management LP	13F	Company	11%	344,438	$8,807,000	—	31 Dec 2020	13F
EMERALD ADVISERS, LLC	13F	Company	11%	340,698	$8,712,000	—	31 Dec 2020	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	10%	322,630	$8,250,000	—	31 Dec 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	10%	321,119	$8,211,000	—	31 Dec 2020	13F
Weiss Multi-Strategy Advisers LLC	13F	Company	9.4%	300,554	$7,685,000	—	31 Dec 2020	13F
Alyeska Investment Group, L.P.	13F	Company	9%	287,896	$7,362,000	—	31 Dec 2020	13F
NORTHERN TRUST CORP	13F	Company	8.3%	265,310	$6,784,000	—	31 Dec 2020	13F
BAKER BROS. ADVISORS LP	13F	Company	7.4%	235,362	$6,018,000	—	31 Dec 2020	13F
JPMORGAN CHASE & CO	13F	Company	6%	192,345	$4,918,000	—	31 Dec 2020	13F
Bank of New York Mellon Corp	13F	Company	5.9%	187,894	$4,805,000	—	31 Dec 2020	13F
EMERALD MUTUAL FUND ADVISERS TRUST	13F	Company	4.3%	138,161	$3,533,000	—	31 Dec 2020	13F
Ikarian Capital, LLC	13F	Company	4.3%	136,697	$3,495,000	—	31 Dec 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	4%	128,726	$3,292,000	—	31 Dec 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	3.4%	107,579	$2,751,000	—	31 Dec 2020	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	3.2%	103,418	$2,645,000	—	31 Dec 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	3%	96,556	$2,469,000	—	31 Dec 2020	13F
Nuveen Asset Management, LLC	13F	Company	2.9%	92,858	$2,374,000	—	31 Dec 2020	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	2.4%	76,600	$1,959,000	—	31 Dec 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	1.7%	55,424	$1,417,000	—	31 Dec 2020	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	1.2%	37,640	$962,000	—	31 Dec 2020	13F
NORGES BANK	13F	Company	1%	33,392	$854,000	—	31 Dec 2020	13F
RAYMOND JAMES & ASSOCIATES	13F	Company	0.87%	27,659	$707,000	—	31 Dec 2020	13F
RHUMBLINE ADVISERS	13F	Company	0.86%	27,417	$701,000	—	31 Dec 2020	13F
Swiss National Bank	13F	Company	0.81%	25,700	$657,000	—	31 Dec 2020	13F
Vontobel Holding Ltd.	13F	Company	0.63%	20,000	$511,000	—	31 Dec 2020	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.61%	19,300	$494,000	—	31 Dec 2020	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.61%	19,300	$493,000	—	31 Dec 2020	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.59%	18,800	$481,000	—	31 Dec 2020	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.58%	18,520	$474,000	—	31 Dec 2020	13F
DEUTSCHE BANK AG\	13F	Company	0.56%	17,859	$456,000	—	31 Dec 2020	13F
CREDIT SUISSE AG/	13F	Company	0.51%	16,089	$412,000	—	31 Dec 2020	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.48%	15,139	$387,000	—	31 Dec 2020	13F
Deutsche Girozentrale DekaBank	13F	Individual	0.45%	14,300	$380,000	—	31 Dec 2020	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.45%	14,467	$370,000	—	31 Dec 2020	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.45%	14,291	$365,000	—	31 Dec 2020	13F
ProShare Advisors LLC	13F	Company	0.39%	12,541	$321,000	—	31 Dec 2020	13F
BANK OF MONTREAL /CAN/	13F	Company	0.37%	11,731	$311,000	—	31 Dec 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.34%	10,829	$277,000	—	31 Dec 2020	13F
MetLife Investment Management, LLC	13F	Company	0.34%	10,730	$274,366	—	31 Dec 2020	13F

Institutional Holders of Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) as of Q1 2021

As of 31 Mar 2021, Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) was held by 88 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 44,993,194 shares. The largest 10 holders included FMR LLC, ORBIMED ADVISORS LLC, FRAZIER MANAGEMENT LLC, Versant Venture Management, LLC, BlackRock Inc., New Leaf Venture Partners, L.L.C., BOXER CAPITAL, LLC, STATE STREET CORP, Vivo Capital, LLC, and VANGUARD GROUP INC. This page lists 88 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

Q1 2021 holders

Holder diff

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.